Innoviva (INVA) Shares Outstanding (Diluted) (2010 - 2026)
Powered by 
Analysis
Innoviva (INVA) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Innoviva | 1.56 Bn | 977.47 Mn | 90.62 Mn | 73.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.42 Mn |
| Mar 31, 2026 | 84.85 Mn |
| Dec 31, 2025 | 84.76 Mn |
| Sep 30, 2025 | 84.96 Mn |
| Jun 30, 2025 | 84.45 Mn |
| Mar 31, 2025 | 62.71 Mn |
| Dec 31, 2024 | 74.19 Mn |
| Sep 30, 2024 | 62.95 Mn |
| Jun 30, 2024 | 62.53 Mn |
| Mar 31, 2024 | 84.53 Mn |
| Dec 31, 2023 | 86.88 Mn |
| Sep 30, 2023 | 86.16 Mn |
| Jun 30, 2023 | 65.49 Mn |
| Mar 31, 2023 | 89.79 Mn |
| Dec 31, 2022 | 95.25 Mn |
| Sep 30, 2022 | 95.83 Mn |
| Jun 30, 2022 | 95.65 Mn |
| Mar 31, 2022 | 93.73 Mn |
| Dec 31, 2021 | 94.31 Mn |
| Sep 30, 2021 | 81.70 Mn |